Thermo-responsive in situ hydrogel enables superior rectal administration and local efficacy of 5-ASA in inflammatory bowel disease

Key Points

• The hydrogel improves the rectal administration of 5-ASA, enhancing its local efficacy in managing inflammatory bowel disease.
• Measured outcomes show a significant increase in drug retention time and targeted delivery with the thermo-responsive hydrogel.
• Assessment using rectal administration techniques reveals notable benefits for localized treatment in patients with inflammatory bowel disease.
• Further validation is needed, as results are based on experimental models; clinical application calls for extensive trials.